CD80 and neoplasm: On the contrary, cytotoxic T-lymphocyte-associated protein 4 (CTLA4) is a negative regulatory inducible receptor for CD80/CD86 and has inhibitory effects on T cell responses, leading to T cell attenuation and tumor cell immune evasion (7).